Skip to main content

CORRECTION article

Front. Pharmacol., 21 November 2022
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1075874

Corrigendum: Wenshen-Jianpi prescription, a Chinese herbal medicine, improves visceral hypersensitivity in a rat model of IBS-D by regulating the MEK/ERK signal pathway

This article is a correction to:

  1. Wenshen-Jianpi prescription, a Chinese herbal medicine, improves visceral hypersensitivity in a rat model of IBS-D by regulating the MEK/ERK signal pathway

    1. Read original article
Tianyuan Jiang,&#x;Tianyuan Jiang1,2†Ran Niu,&#x;Ran Niu1,2†Qian Liu,&#x;Qian Liu1,2†Yuhan FuYuhan Fu3Xiaoying Luo,Xiaoying Luo1,2Tao Zhang,Tao Zhang1,2Baoqi Wu,Baoqi Wu1,2Juan HanJuan Han4Yang Yang,Yang Yang1,2Xiaolan Su,Xiaolan Su1,2Jiande D. Z. ChenJiande D. Z. Chen5Gengqing Song Gengqing Song6*Wei Wei, Wei Wei1,2*
  • 1Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing, China
  • 2Laboratory of Functional Gastrointestinal Disorders Diagnosis and Treatment of Traditional Chinese Medicine, Beijing, China
  • 3Department of Internal Medicine, MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH, United States
  • 4Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China
  • 5Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States
  • 6Department of Gastroenterology and Hepatology, MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH, United States

A Corrigendum on
Wenshen-Jianpi prescription, a Chinese herbal medicine, improves visceral hypersensitivity in a rat model of IBS-D by regulating the MEK/ERK signal pathway

by Jiang T, Niu R, Liu Q, Fu Y, Luo X, Zhang T, Wu B, Han J, Yang Y, Su X, Chen JDZ, Song G and Wei W (2022). Front. Pharmacol. 13:955421. doi: 10.3389/fphar.2022.955421

In the published article, there was an error in Figure 2A as published. The version that was published was an old pre-review version. The corrected Figure 2A appears below:

FIGURE 2
www.frontiersin.org

FIGURE 2. Detailed procedures for the experiments and their general conditions. (A) Protocol diagram of the time course involved in the experimental procedures of the IBS-D rat model induced and the intervention.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: rat model of IBS-D, visceral hypersensitivity, Chinese herbal medicine, colon, hippocampus, MEK/ERK signal pathway

Citation: Jiang T, Niu R, Liu Q, Fu Y, Luo X, Zhang T, Wu B, Han J, Yang Y, Su X, Chen JDZ, Song G and Wei W (2022) Corrigendum: Wenshen-Jianpi prescription, a Chinese herbal medicine, improves visceral hypersensitivity in a rat model of IBS-D by regulating the MEK/ERK signal pathway. Front. Pharmacol. 13:1075874. doi: 10.3389/fphar.2022.1075874

Received: 21 October 2022; Accepted: 04 November 2022;
Published: 21 November 2022.

Edited and reviewed by:

Mingyu Sun, Shanghai University of Traditional Chinese Medicine, China

Copyright © 2022 Jiang, Niu, Liu, Fu, Luo, Zhang, Wu, Han, Yang, Su, Chen, Song and Wei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Gengqing Song, songgavin2010@gmail.com; Wei Wei, sxxtyy@sina.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.